Results
|
|
1.
|
|
|
|
2.
|
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. MedStar authors:
Year: 2013
Citation: - Lancet. 382(9906):1714-22, 2013 Nov 23.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Observational Study
- Research Support, Non-U.S. Gov't
All authors: - Alu M, Antoniucci D, Ariti C, Baber U, Berger PB, Chieffo A, Cohen DJ, Colombo A, Dangas G, Gibson CM, Henry TD, Hermiller JB, Iakovou I, Kini AS, Krucoff MW, Mehran R, Moliterno DJ, Pocock S, Sartori S, Shawl F, Steg PG, Stuckey T, Waksman R, Weisz G, Witzenbichler B
|
|
|
3.
|
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. MedStar authors:
Year: 2012
Citation: - Lancet. 379(9814):432-44, 2012 Feb 4.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Meta-Analysis
- Research Support, Non-U.S. Gov't
All authors: - Albain K, Bergh J, Clarke M, Cutter D, Darby S, Davies C, Di Leo A, Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Godwin J, Gray R, McGale P, Pan HC, Peto R, Piccart M, Pritchard K, Swain S, Taylor C, Wang YC
|
|
|
4.
|
|
|
|
5.
|
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.[Erratum appears in Lancet. 2012 Aug 11;380(9841):564] MedStar authors:
- Burnett, Mary Susan
- Devaney, Joseph M
Citation: - Lancet. 380(9841):572-80, 2012 Aug 11.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Meta-Analysis
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Abecasis GR, Altshuler D, Anand S, Ardissino D, Barbalic M, Berger K, Blankenberg S, Boehnke M, Boer JM, Boerwinkle E, Burnett MS, Burtt NP, Buysschaert I, Chen L, Clarke R, Cupples LA, Daly MJ, Danesh J, de Bakker PI, de Boer A, de Faire U, Demissie S, Deneer VH, Devaney J, Diemert P, Ding EL, Do R, El Mokhtari NE, Elbers CC, Elosua R, Engert JC, Epstein SE, Erdmann J, Fischer M, Fox KA, Frikke-Schmidt R, Frossard P, Gabriel S, Gigante B, Girelli D, Gonzalez E, Grobbee DE, Guiducci C, Hall AS, Havulinna A, Hengstenberg C, Hindy G, Hofker MH, Holm H, Hopewell JC, Ingelsson E, Jensen MK, Johnson T, Kamphuisen PW, Kathiresan S, Klungel OH, Konig IR, Lambrechts D, Li M, Lokki ML, Maitland-van der Zee AH, Mannucci PM, Marrugat J, Martinelli N, McKeown PP, McPherson R, Melander O, Mohlke KL, Mooser V, Morgan T, Musunuru K, Newton-Cheh C, Nieminen MS, O'Donnell CJ, Onland-Moret NC, Ordovas JM, Orho-Melander M, Overvad K, Patterson CC, Peden J, Peloso GM, Peltonen L, Perola M, Peters BJ, Pirruccello JP, Purcell S, Rader DJ, Rasheed A, Reilly MP, Rimm E, Ripatti S, Roberts R, Rubin D, Saleheen D, Salomaa V, Samani NJ, Schafer A, Schillert A, Schreiber S, Schrezenmeir J, Schunkert H, Schwartz SM, Sinisalo J, Siscovick D, Spertus J, Stefansson K, Stewart A, Stoll M, Surakka I, Surti A, Thompson JF, Thorgeirsson G, Thorleifsson G, Thorsteinsdottir U, Tybjaerg-Hansen A, Van de Werf F, van der Schouw YT, Verschuren WM, Voight BF, Watkins H, Wijmenga C, Wild P, Willenborg C, Willer C, Zeller T, Ziegler A
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. MedStar authors:
- Waksman, Ron
- Weissman, Neil J
Year: 2013
Citation: - Lancet. 381(9869):836-44, 2013 Mar 9.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Trial
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Bose D, Degen H, Erbel R, Erne P, Haude M, Koolen J, Prati F, Verheye S, Vermeersch P, Waksman R, Weissman N, Wijnbergen I
|
|
|
9.
|
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. [Review] MedStar authors:
Year: 2014
Citation: - Lancet. 384(9938):164-72, 2014 Jul 12.
Medline publication type:
- Journal Article
- Meta-Analysis
- Research Support, U.S. Gov't, P.H.S.
- Review
All authors: - Baselga J, Bergh J, Blohmer J, Blumenthal G, Bogaerts J, Bonnefoi H, Cameron D, Cortazar P, Costantino JP, Ditsch N, Eidtmann H, Eiermann W, Fasching PA, Gerber B, Geyer CE Jr, Gianni L, Justice R, Loibl S, Mamounas EP, Mehta K, Paik S, Pazdur R, Perou C, Piccart M, Prowell T, Rastogi P, Semiglazov V, Slaets L, Sridhara R, Swain SM, Tang S, Untch M, Valagussa P, von Minckwitz G, Wickerham DL, Wolmark N, Zhang L
|
|
|
10.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(6):461-71, 2013 May.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
11.
|
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. MedStar authors:
Year: 2012
Citation: - Lancet Oncology. 13(7):734-42, 2012 Jul.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Anderson SJ, Baez-Diaz L, Brufsky AM, Costantino JP, Dakhil S, Falkson CI, Fehrenbacher L, Geyer CE Jr, Gralow JR, King KM, Lad T, Lembersky BC, Mamounas EP, Paterson AH, Perez EA, Robidoux A, Swain SM, Weir LM, Wolmark N, Zheng P
|
|
|
12.
|
|
|
|
13.
|
Physicians in the digital age. MedStar authors:
Year: 2022
Citation: - Lancet. 399(10321):231, 2022 01 15.
Institution: - MedStar Washington Hospital Center
Department: - Urology; Literature and Medicine
Medline publication type:
|
|
|
14.
|
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. MedStar authors:
Year: 2016
Citation: - Lancet. 387(10034):2218-25, 2016 May 28.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Observational Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Ailawadi G, Alu MC, Babaliaros V, Cohen DJ, D'Agostino RB Jr, Devireddy C, Greason KL, Hahn RT, Herrmann HC, Jaber WA, Kapadia S, Kereiakes D, Kodali S, Leipsic J, Leon MB, Lim S, Mack MJ, Makkar RR, Malaisrie SC, Miller DC, Moses JW, Parvataneni R, Pibarot P, Smalling R, Smith CR, Suri R, Svensson LG, Szeto WY, Thourani VH, Tuzcu EM, Webb JG, Weissman NJ, Whisenant BK, Williams M
|
|
|
15.
|
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors:
Year: 2017
Citation: - Lancet Oncology. 18(11):1493-1501, 2017 Nov
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II
|
|
|
16.
|
ANTARCTIC: platelet function testing to adjust therapy. MedStar authors:
- Garcia-Garcia, Hector M
- Hideo-Kajita, Alexandre
- Waksman, Ron
Year: 2017
Citation: - Lancet. 389(10075):1192-1193, 2017 Mar 25
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Garcia-Garcia HM, Hideo-Kajita A, Waksman R
|
|
|
17.
|
|
|
|
18.
|
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. MedStar authors:
Year: 2019
Citation: - Lancet Oncology. 20(1):88-99, 2019 01.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - Bandos H, Brufsky AM, Chia SK, Dakhil SR, Fehrenbacher L, Geyer CE Jr, Graham ML, Jeong JH, Lembersky BC, Mamounas EP, McCarron EC, Paik S, Rastogi P, Seay TE, Soori GS, Swain SM, Wade JL 3rd, Walshe JM, Wickerham DL, Wolmark N
|
|
|
19.
|
Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial. MedStar authors:
- Asch, Federico M
- Satler, Lowell F
- Waksman, Ron
Year: 2020
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abernethy W, Asch FM, Bhatt DL, Chakravarty T, Chehab B, Chen C, Cheng W, Cunningham M, Fontana GP, Groh M, Heimansohn D, Hermiller J, Jilaihawi H, Kapadia S, Makkar RR, Matthews R, Nakamura M, Pichard AD, Ramana RK, Reardon MJ, Ruiz CE, Russo MJ, Satler LF, Sharma R, Waksman R, Worthley S, Yong G, Yoon SH
|
|
|
20.
|
|
|
|
21.
|
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. MedStar authors:
Citation: - Lancet Oncology. 14(9):901-8, 2013 Aug.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Blay JY, Chawla S, Choy E, Ferrari S, Grimer R, Henshaw R, Jacobs I, Kroep J, Qian Y, Reichardt P, Rutkowski P, Schuetze S, Seeger L, Skubitz K, Staddon A, Thomas D
|
|
|
22.
|
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. MedStar authors:
Citation: - Lancet. 385(9986):2477-84, 2015 Jun 20.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Akin J, Anderson WN, Babaliaros V, Bavaria J, Blackstone EH, Brown DL, Davidson MJ, Douglas PS, Fontana GP, Hahn RT, Herrmann HC, Kapadia S, Kodali SK, Leon MB, Mack MJ, Makkar RR, Miller DC, Moses JW, PARTNER 1 trial investigators, Pichard A, Smith CR, Svensson LG, Thourani VH, Tuzcu EM, Webb JG, Williams M
|
|
|
23.
|
|
|
|
24.
|
Examining empathy. MedStar authors:
Citation: - Lancet. 386(10004):1618, 2015 Oct 24.
Institution: - MedStar Washington Hospital Center
Department: - Urology; Literature and Medicine
Medline publication type:
|
|
|
25.
|
Reactions to START:REACTS. MedStar authors:
Year: 2022
Citation: - Lancet. 400(10363):1583, 2022 11 05.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Abboud JA, Amini MH, Familiari F, Murthi AM, Srikumaran U, Verma NN
|
|
|
26.
|
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. MedStar authors:
Year: 2015
Citation: - Lancet Oncology. 16(9):1037-48, 2015 Sep.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Liu Q, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
|
|
|
27.
|
Stillbirths: the vision for 2020. MedStar authors:
Year: 2011
Citation: - Lancet. 377(9779):1798-805, 2011 May 21.
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology, Maternal-Fetal Medicine
Medline publication type:
- Comment
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Belizan JM, Bhutta ZA, Darmstadt GL, Flenady V, Goldenberg RL, Lancet's Stillbirths Series steering committee, Mabeya H, McClure EM, Reddy UM, Rubens CE
|
|
|
28.
|
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. MedStar authors:
Year: 2017
Citation: - Lancet Oncology. 18(12):1600-1609, 2017 Dec
Institution: - MedStar Franklin Square Hospital
Medline publication type:
All authors: - Brahmer JR, Csoszi T, Cuffe S, Deitz AC, Fulop A, Gottfried M, Hotta K, Hui R, Lubiniecki GM, O'Brien M, Peled N, Rangwala R, Rao S, Reck M, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Zhang J
|
|
|
29.
|
Long-acting antiretrovirals and HIV treatment adherence. [Review] MedStar authors:
Year: 2023
Citation: - The Lancet. HIV. 10(5):e332-e342, 2023 05.
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Review
All authors: - Archary M, Decloedt E, Gandhi M, Geng EH, Mellors JW, Mofenson LM, Nachega JB, Nachman S, Rawat A, Scarsi KK, Scott RK, Wilson L
|
|
|
30.
|
We, the animals. MedStar authors:
Citation: - Lancet. 386(10009):2132, 2015 Nov 28.
Institution: - MedStar Washington Hospital Center
Department: - Urology; Literature and Medicine
Medline publication type:
|
|
|
31.
|
Laughter is the best medicine. MedStar authors:
Year: 2023
Citation: - Lancet. 401(10391):1844, 2023 06 03.
Department:
- MedStar Health
- Office of Physician Wellbeing
Medline publication type:
|
|
|
32.
|
Laughter is the best medicine. MedStar authors:
Year: 2023
Citation: - Lancet. 401(10391):1844, 2023 06 03.
Department:
- MedStar Health
- Office of Physician Wellbeing
Medline publication type:
|
|
|
33.
|
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial. MedStar authors:
Year: 2019
Citation: - The Lancet Diabetes & Endocrinology. 7(8):596-605, 2019 08.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Gonzalez-Galvez G, Gron R, Halladin N, Haluzik M, Jermendy G, Kok A, Orsy P, Sabbah M, Sesti G, Silver R
|
|
|
34.
|
Comprehensive review of the national surveys that assess E-cigarette use domains among youth and adults in the United States. [Review] MedStar authors:
- Obisesan, Olufunmilayo
- Osei, Albert D
Year: 2023
Citation: - Lancet Regional Health. Americas.. 23:100528, 2023 Jul.
Institution:
- MedStar Union Memorial Hospital
- MedStar Union Memorial Hospital
Department:
- Internal Medicine
- Internal Medicine Residency
Medline publication type:
All authors: - Benjamin EJ, Bhatnagar A, Blaha MJ, Boakye E, DeFilippis AP, El Shahawy O, Erhabor J, Hirsch GA, Lee J, Mirbolouk M, Obisesan O, Osei AD, Osuji N, Robertson RM, Stokes AC, Tasdighi E
|
|
|
35.
|
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial. MedStar authors:
Year: 2015
Citation: - Lancet. 386(9992):452-60, 2015 Aug 1.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Barter PJ, Brewer HB, Ford J, Hovingh GK, Kastelein JJ, Rader DJ, Round P, Saleheen D, van Deventer SJ
|
|
|
36.
|
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. MedStar authors:
Year: 2016
Citation: - Lancet. 387(10013):31-9, 2016 Jan 2.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Study
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Toelg R, von Birgelen C, Waksman R, Wijns W
|
|
|
37.
|
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2017
Citation: - Lancet. 390(10105):1843-1852, 2017 Oct 21.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R
|
|
|
38.
|
|
|
|
39.
|
Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid gland. [Review] MedStar authors:
- Burman, Kenneth D
- Wartofsky, Leonard
Year: 2020
Citation: - Lancet Oncology. 21(11):e528-e537, 2020 11.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Araque KA, Avadhanula S, Burman KD, Del Rivero J, Filie AC, Gubbi S, Kebebew E, Klubo-Gwiezdzinska J, Raffeld M, Thakur S, Wartofsky L, Welch J
|
|
|
40.
|
Urgent need for neurological care in Ukraine. MedStar authors:
Year: 2023
Citation: - Lancet Neurology. 22(3):202-203, 2023 Mar.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Tomycz LD, Markosian C, Strelko O, Sirko A, Lovha M, Armonda RA
|
|
|
41.
|
|
|
|
42.
|
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial. MedStar authors:
Year: 2017
Citation: - The Lancet Diabetes & Endocrinology. 5(5):355-366, 2017 May
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Axelsen M, Bain SC, Cariou B, DeVries JH, Piletic M, Rose L, Rowe E
|
|
|
43.
|
Overcoming disparities for sexual and gender minority patients and providers in gastroenterology and hepatology: introduction to Rainbows in Gastro. MedStar authors:
Year: 2023
Citation: - The Lancet. Gastroenterology & Hepatology. 8(4):299-301, 2023 Apr.
Institution: - MedStar Franklin Square Medical Center
Department: - Center for Digestive Disease
Medline publication type:
All authors: - Duong N, Lee TH, Newman KL, Goldowsky A, Jencks KJ, Chedid V, Barrow J, Burbridge R, Chiang A, Targownik L, Simonetto DA, Paul S
|
|
|
44.
|
|
|
|
45.
|
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. MedStar authors:
Year: 2018
Citation: - The Lancet Diabetes & Endocrinology. 6(4):275-286, 2018 04.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Andreassen C, Aroda VR, Lingvay I, Ludemann J, Navarria A, Pratley RE, SUSTAIN 7 investigators, Viljoen A
|
|
|
46.
|
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. MedStar authors:
Year: 2021
Citation: - The Lancet Infectious Diseases. 21(2):213-225, 2021 02.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
All authors: - Ariyasu M, Clevenbergh P, Echols R, Kaye KS, Kollef M, Matsunaga Y, Menon A, Nagata TD, Pogue JM, Shorr AF, Timsit JF, Wunderink RG, Zeitlinger M
|
|
|
47.
|
Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK). MedStar authors:
Year: 2023
Citation: - The Lancet Infectious Diseases. 2023 May 11
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
All authors: - Altarac D, Chen L, Du B, Isaacs R, Kaye KS, Lewis D, Miller A, O'Donnell J, Poirier GE, Rana K, Reinhart H, Shorr AF, Srinivasan S, Wunderink RG
|
|
|
48.
|
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(12):1183-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N
|
|
|
49.
|
Hypothyroidism. [Review] MedStar authors:
Year: 2017
Citation: - Lancet. 390(10101):1550-1562, 2017 Sep 23.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Bianco AC, Chaker L, Jonklaas J, Peeters RP
|
|
|
50.
|
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.O - Lancet. 393(10174):899-909, 2019 03 02. MedStar authors:
Year: 2019
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology/Maternal-Fetal Medicine
Medline publication type:
All authors: - Bacq Y, Bozkurt N, Brun-Furrer R, Bull L, Chambers J, Chappell LC, Di Illio C, Estiu MC, Geenes V, Grymowicz M, Gunaydin B, Hague WM, Haslinger C, Hu Y, Kawakita T, Kebapcilar AG, Kebapcilar L, Kohari K, Kondrackiene J, Koster MPH, Kowalska-Kanka A, Kupcinskas L, Lee RH, Locatelli A, Macias RIR, Marschall HU, Oudijk MA, Ovadia C, Raz Y, Rimon E, Seed PT, Shan D, Shao Y, Sklavounos A, Thornton JG, Tribe R, Tripodi V, Williamson C, Yayla Abide C, Yenidede I
|
|
|
51.
|
Health-care disparities for foreign residents in Japan. MedStar authors:
Year: 2019
Citation: - Lancet. 393(10174):873-874, 2019 03 02.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Internal Medicine
Medline publication type:
All authors: - Hashimoto H, Jimba M, Sawada T, Yasukawa K
|
|
|
52.
|
Physician burnout in the modern era. MedStar authors:
Year: 2019
Citation: - Lancet. 393(10174):868-869, 2019 03 02.
Institution: - MedStar Washington Hospital Center
Department: - Urology; Literature and Medicine
Medline publication type:
|
|
|
53.
|
Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study. MedStar authors:
- Brewer, H Bryan
- Craig, Paige E
- Garcia-Garcia, Hector M
- Kolm, Paul
- Torguson, Rebecca
- Waksman, Ron
- Zou, Quan
Year: 2019
Citation: - Lancet. 394(10209):1629-1637, 2019 11 02.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Ali ZA, Artis AK, Brewer HB, Cate TT, Craig PE, Di Mario C, Dube S, Garcia-Garcia HM, Kazziha S, Kim C, Kolm P, Lewis S, LRP Investigators, Powers E, Regar E, Shah P, Singh V, Skinner WH, Torguson R, van der Ent M, Waksman R, Wong SC, Wykrzykowska J, Zou Q
|
|
|
54.
|
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. MedStar authors:
Year: 2019
Citation: - Lancet Oncology. 20(12):1719-1729, 2019 12.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Blay JY, Chawla S, Choy E, Dai T, Gelderblom H, Grimer RJ, Henshaw R, Jandial D, Le Cesne A, Palmerini E, Reichardt P, Rutkowski P, Schuetze SM, Seeger L, Skubitz K
|
|
|
55.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. MedStar authors:
Year: 2020
Citation: - Lancet Oncology. 21(4):519-530, 2020 Apr.
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Benyunes MC, Ciruelos E, Clark E, CLEOPATRA study group, Cortes J, Im SA, Im YH, Kim SB, Knott A, Loi S, Miles D, Monturus E, Restuccia E, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
56.
|
|
|
|
57.
|
5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. MedStar authors:
Citation: - Lancet. 385(9986):2485-91, 2015 Jun 20.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Akin JJ, Anderson WN, Babaliaros VC, Davidson MJ, Douglas PS, Fontana GP, Herrmann HC, Kapadia SR, Kodali S, Leon MB, Mack MJ, Makkar RR, Miller DC, PARTNER trial investigators, Pichard AD, Smith CR, Svensson LG, Szeto WY, Thourani VH, Tuzcu EM, Webb JG, Williams MR
|
|
|
58.
|
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. MedStar authors:
Citation: - Lancet Oncology. 16(8):957-66, 2015 Aug.
Institution: - MedStar Washington Hospital Center
Department: - Surgery/Colorectal Surgery
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
All authors: - Avila K, Cataldo PA, Chow OS, Coutsoftides T, Dietz DW, Fichera A, Garcia-Aguilar J, Herzig DO, Hunt SR, Kumar AS, Marcet JE, Oommen S, Patil S, Polite BN, Smith DD, Stamos MJ, Ternent CA, Timing of Rectal Cancer Response to Chemoradiation Consortium, Varma MG
|
|
|
59.
|
Novel remedies. MedStar authors:
Citation: - Lancet. 386(10000):1223, 2015 Sep 26.
Institution: - MedStar Washington Hospital Center
Department: - Urology; Literature and Medicine
Medline publication type:
|
|
|
60.
|
Angels of history. MedStar authors:
Year: 2023
Citation: - Lancet. 401(10389):1645, 2023 05 20.
Department:
- MedStar Health
- Office of Physician Wellbeing
Medline publication type:
|
|
|
61.
|
Laughter is the best medicine. MedStar authors:
Year: 2023
Citation: - Lancet. 401(10391):1844, 2023 06 03.
Department:
- MedStar Health
- Office of Physician Wellbeing
Medline publication type:
|
|
|
62.
|
The expectations trap in medicine. MedStar authors:
Year: 2023
Citation: - Lancet. 402(10408):1125, 2023 Sep 30.
Department:
- MedStar Health
- Office of Physician Wellbeing
Medline publication type:
|
|
|
63.
|
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. MedStar authors:
Year: 2019
Citation: - The Lancet Respiratory Medicine. 7(3):227-238, 2019 03.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Ahmad F, Aman J, Amouyel P, Archer SL, Argula R, Arora A, Austin ED, Badesch D, Bakshi S, Barnett C, Batai K, Benza R, Bhatt N, Bleda M, Bogaard HJ, Burger CD, Cebola I, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Desai AA, Elliott CG, Elwing J, Eyries M, Ferrer J, Fortin T, Franke A, Frantz RP, Frost A, Gall H, Garcia JGN, Germain M, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Graf S, Hadinnapola C, Haimel M, Hanscombe KB, Harbaum L, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Humbert M, Ivy D, Kaakinen M, Karnes JH, Kiely DG, Kittles R, Klinger J, Knight J, Kovacs G, Lahm T, Laudes M, Lawrie A, Lutz K, Machado RD, Marsolo K, Martin LJ, Moledina S, Montani D, Morrell NW, Nathan SD, Newnham M, Nichols WC, Noordegraaf AV, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Pauciulo MW, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rehman Z, Rhodes CJ, Robbins I, Roden DM, Rosenzweig EB, Ross RVM, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Soubrier F, Southgate L, Suntharalingam J, Swietlik EM, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Tregouet DA, Trembath RC, UK NIHR BioResource Rare Diseases Consortium, UK PAH Cohort Study Consortium, Ulrich A, US PAH Biobank Consortium, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilkins MR, Wilt J, Wort SJ, Yung D
|
|
|
64.
|
Using patient safety-event report data to assess health-IT safety: benefits and challenges. MedStar authors:
- Hettinger, Aaron Z
- Howe, Jessica L
- Ratwani, Raj M
Year: 2019
Citation: - The Lancet. Digital Health. 1(3):e104-e105, 2019 07.
Institution:
- MedStar Institute for Innovation
- MedStar Washington Hospital Center
Department:
- Emergency Medicine
- National Center for Human Factors in Healthcare
Medline publication type:
All authors: - Hettinger AZ, Howe JL, Ratwani RM
|
